| Severe hypocalcemia associated with denosumab in metastatic castration-resistant prostate cancer: risk factors and precautions for treating physicians KA Autio, A Farooki, IG Glezerman, A Chan, CW Schneider, HC Barr, ... Clinical Genitourinary Cancer 13 (4), e305-e309, 2015 | 32 | 2015 |
| Retrospective analysis of posaconazole suspension dosing strategies in a pediatric oncology population: single-center experience S Mathew, ML Kussin, D Liu, M Pozotrigo, B Seyboth, J Thackray, SQ Yan, ... Journal of the Pediatric Infectious Diseases Society 6 (3), e149-e151, 2017 | 11 | 2017 |
| Retrospective evaluation of palifermin use in nonhematopoietic stem cell transplant pediatric patients D Liu, B Seyboth, S Mathew, SW Gilheeney, AJ Chou, E Drill, R Kobos Journal of Pediatric Hematology/Oncology 39 (4), e177-e182, 2017 | 10 | 2017 |
| Busulfan pharmacokinetics and precision dosing: Are patients with Fanconi anemia different? PA Mehta, C Emoto, T Fukuda, B Seyboth, A Teusink-Cross, SM Davies, ... Biology of Blood and Marrow Transplantation 25 (12), 2416-2421, 2019 | 9 | 2019 |
| Voriconazole dosing in children younger than 3 years undergoing cancer chemotherapy or hematopoietic stem cell transplantation SQ Yan, B Seyboth, R Kobos, A Eaton, SK Seo, N Cohen Journal of the Pediatric Infectious Diseases Society 7 (2), 169-171, 2018 | 9 | 2018 |
| Antimicrobial stewardship efforts to manage a pentamidine shortage A Paskovaty, CD Lucarelli, P Patel, M Ryan, B Seyboth, J Thackray, ... American Journal of Health-System Pharmacy 71 (23), 2014-2018, 2014 | 6 | 2014 |
| Risk assessment for severe hypocalcemia requiring hospitalization with denosumab. KA Autio, A Farooki, I Glezerman, A Chan, HC Barr, BM Seyboth, ... Journal of Clinical Oncology 31 (6_suppl), 115-115, 2013 | 3 | 2013 |
| Checkpoint inhibitor and multireceptor tyrosine kinase inhibitor combination in relapsed refractory sarcomas: A single institution series. N Mittal, B Seyboth, P Kent Journal of Clinical Oncology 40 (16_suppl), 11529-11529, 2022 | 1 | 2022 |
| Partial Response to Naxitamab for Brain Metastasis in Neuroblastoma C Onyeukwu, A Williams, B Seyboth, L Muñoz, G Scaria, P Kent Journal of Pediatric Hematology/Oncology 46 (2), e188-e190, 2024 | | 2024 |
| Busulfan pharmacokinetics (PK): is it different in patients with fanconi anemia? P Mehta, C Emoto, T Fukuda, B Seyboth, S Davies, A Teusink-Cross, ... BONE MARROW TRANSPLANTATION 52, S113-S113, 2017 | | 2017 |
| Fosaprepitant use in children and adolescents at Memorial Sloan Kettering Cancer Center. D Liu, K Horiates, S Mathew, M Pozotrigo, J Thackray, M Kussin, SQ Yan, ... Journal of Clinical Oncology 35 (15_suppl), 10575-10575, 2017 | | 2017 |
